Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C V Granger

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Health Services Research|November 5, 1997
Development of function-related groups version 2.0: a classification system for medical rehabilitationM G Stineman, C J Tassoni, J J Escarce, et al.
Archives of Physical Medicine and Rehabilitation|October 13, 2000
The WeeFIM instrument: its utility in detecting change in children with developmental disabilitiesK J Ottenbacher, M E Msall, N Lyon, et al.
Developmental Medicine and Child Neurology|October 1, 1996
The stability and equivalence reliability of the functional independence measure for children (WeeFIM)K J Ottenbacher, E T Taylor, M E Msall, et al.
The Orthopedic Clinics of North America|April 1, 1976
The pediatrician and myelodysplasiaM J Bull, W Shucart, J S Haller, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 1, 1995
A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients. Multiple Sclerosis Collaborative Research Group (MSCRG)L D Jacobs, D L Cookfair, R A Rudick, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 12, 1999
A profile of multiple sclerosis: the New York State Multiple Sclerosis ConsortiumL D Jacobs, K E Wende, C M Brownscheidle, et al.
Annals of Neurology|December 16, 2000
Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research GroupJ S Fischer, R L Priore, L D Jacobs, et al.
Annals of Neurology|February 5, 1998
Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research GroupJ H Simon, L D Jacobs, M Campion, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2003
Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis ConsortiumB Weinstock-Guttman, L D Jacobs, C M Brownscheidle, et al.
Neurology|August 1, 1997
Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)R A Rudick, D E Goodkin, L D Jacobs, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Health Services Research|November 5, 1997
Development of function-related groups version 2.0: a classification system for medical rehabilitationM G Stineman, C J Tassoni, J J Escarce, et al.
Archives of Physical Medicine and Rehabilitation|October 13, 2000
The WeeFIM instrument: its utility in detecting change in children with developmental disabilitiesK J Ottenbacher, M E Msall, N Lyon, et al.
Developmental Medicine and Child Neurology|October 1, 1996
The stability and equivalence reliability of the functional independence measure for children (WeeFIM)K J Ottenbacher, E T Taylor, M E Msall, et al.
The Orthopedic Clinics of North America|April 1, 1976
The pediatrician and myelodysplasiaM J Bull, W Shucart, J S Haller, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 1, 1995
A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients. Multiple Sclerosis Collaborative Research Group (MSCRG)L D Jacobs, D L Cookfair, R A Rudick, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 12, 1999
A profile of multiple sclerosis: the New York State Multiple Sclerosis ConsortiumL D Jacobs, K E Wende, C M Brownscheidle, et al.
Annals of Neurology|December 16, 2000
Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research GroupJ S Fischer, R L Priore, L D Jacobs, et al.
Annals of Neurology|February 5, 1998
Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research GroupJ H Simon, L D Jacobs, M Campion, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2003
Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis ConsortiumB Weinstock-Guttman, L D Jacobs, C M Brownscheidle, et al.
Neurology|August 1, 1997
Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)R A Rudick, D E Goodkin, L D Jacobs, et al.
Pageof 13